Genetic studies have established that the cysteine protease CED-3 plays a central role in coordinating programmed cell death in Caenorhabditis elegans. However, it remains unclear how CED-3 activation results in cell death because few substrates for this protease have been described. We have used a global proteomics approach to seek substrates for CED-3 and have identified 22 worm proteins that undergo CED-3-dependent proteolysis. Proteins that were found to be substrates for CED-3 included the cytoskeleton proteins actin, myosin light chain, and tubulin, as well as proteins involved in ATP synthesis, cellular metabolism, and chaperone function. We estimate that approximately 3% of the C. elegans proteome is susceptible to CED-3-dependent proteolysis. Notably, the endoplasmic reticulum chaperone calreticulin, which has been implicated in the recognition of apoptotic cells by phagocytes, was cleaved by CED-3 and was also cleaved by human caspases during apoptosis. Inhibitors of caspase activity blocked the appearance of calreticulin on the surface of apoptotic cells, suggesting a mechanism for the surface display of calreticulin during apoptosis. Further analysis of these substrates is likely to yield important insights into the mechanism of killing by CED-3 and its human caspase counterparts.
INTRODUCTION
The caspase family of cysteine proteases have been implicated in the regulation of programmed cell death in numerous organisms, from simple invertebrates to man (1) . Caspases are present in most cells as inactive proenzymes and become activated during apoptosis through diverse signalling pathways (2, 3) . Upon activation, caspases promote programmed cell death by restricted proteolysis of numerous proteins within the dying cell (4) . Caspase-dependent proteolytic events produce dramatic rearrangements of the cellular architecture and engulfment of the dying cell by phagocytes (5) .
The nematode C. elegans has contributed greatly to our understanding of the regulation of cell death in metazoans through discovery of a series of cell death defective (ced) genes (6, 7) . In several cases, this led directly to the discovery of a role for their mammalian counterparts in the regulation of apoptosis, the caspases being a notable example (8) (9) (10) . The worm caspase, CED-3, has been established as essential for the great majority of developmental-related programmed cell deaths in the worm (6, 11) . Similar to mammalian caspases, CED-3 is probably present in most cells as an inactive precursor but becomes activated in cells fated to die during development. CED-3 activation is achieved through recruitment of the inactive CED-3 precursor to the scaffold protein CED-4, which assembles into a tetrameric complex (12) . The latter event is normally prevented by CED-9, which represses CED-4 tetramerization and CED-3 recruitment (12,13).
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However, while CED-3 is firmly established as a central participant in the molecular control of programmed cell death in the worm, how activation of this protease results in cell death is obscure as few substrates for CED-3 have been identified thus far. Understanding how CED-3 kills cells in the worm is of considerable interest, not only because this is likely to shed further light upon how programmed cell death is coordinated in this organism, but this is also likely to generate insight into how human caspases promote apoptosis. The observation that a single caspase is sufficient to coordinate apoptosis in the worm suggests that CED-3 harbors all of the activities that have subsequently become allocated to several different caspases in higher organisms.
Here we have used two-dimensional gel-based proteomics to seek substrates for CED-3. This approach yielded 22 substrates and included proteins involved in protein and DNA synthesis, chaperone function, cellular metabolism and the cytoskeleton. We estimate that approximately 3% of the worm proteome is susceptible to CED-3-dependent proteolysis. These data suggest that CED-3 promotes cell death through simultaneously targeting diverse cellular functions. Detailed analysis of these substrates is likely to yield important insights into the mechanism of killing by CED-3.
EXPERIMENTAL PROCEDURES
Reagents-The following antibodies were used for immunoblotting: anti-CED-3 C-20 (Santa Cruz, UK), anti-GST (BD Pharmingen, UK), antibeta tubulin (ICN, UK), anti-calreticulin polyclonal antibody (Affinity Bioreagents, USA) and anti-calreticulin monoclonal antibody (Transduction Laboratories, UK).
Anticalreticulin polyclonal antibody was also used for surface immunostaining in conjunction with antirabbit-Alexafluor 488 as a secondary antibody (Molecular Probes, UK). Rabbit polyclonal antibodies were generated against recombinant CED-3, as follows. Briefly, His-CED-3 221-503 was expressed in E. coli, purified over Ni-NTA agarose and rabbits immunized with the purified protein. Polyclonal antibodies against p17 and p13 domain peptides of CED-3 were also generated and affinity purified using the immunization peptides. The peptides z-VAD-fmk, Ac-DEVD-AFC, Ac-LEHD-AFC, Ac-IETD-AFC and Ac-YVAD-AFC were purchased from Bachem (UK). 17 cm IPG strips (pH 3-6 and pH [5] [6] [7] [8] , easymelt agarose and Bio-Lyte ampholytes TM were obtained from Biorad (UK). The serine p r o t e a s e i n h i b i t o r s , tosylphenylalanylchloromethane (TPCK) and 3,4-dichloroisocoumarin (DCI) were purchased from Merck (UK). Unless otherwise indicated, all other reagents were purchased from Sigma (Ireland) Ltd.
Plasmids and site-directed mutagenesis-The CED-3 221-503 ORF was cloned from a pQE30-CED-3 221-503 template (kindly provided by Dr. Shai Shaham) into the pGEX4TK2 vector to generate GST-tagged CED-33 . Crt-1, Tbb-2 and Ftt-2 ORFs were amplified by PCR from a C. elegans cDNA library (Origene) and cloned into the pET45b vector. The human calreticulin ORF was amplified by PCR from an IMAGE clone (MRC, UK) and inserted into pcDNA3. Site-directed mutagenesis was carried out using the Quickchange kit (Stratagene). All plasmids were verified by DNA sequencing.
Expression and purification of recombinant CED-3-E. coli DH5α cells were transformed with pGEX4TK2-CED-3 221-503 . CED-3 protein expression was induced by addition of 100 µM IPTG to culture media followed by a 3 hour incubation at 25 o C. Proteins were affinity purified on glutathione sepharose, as previously described, and eluted in protease reaction buffer (PRB; 50 mM HEPES, pH7.4, 75 mM NaC1, 0.1 % CHAPS, 2 mM DTT) with 10 mM glutathione. CED-3 was then active site titrated against AcDEVD-AFC, using zVAD-fmk as an inhibitor.
Fluorimetry assays-Reactions containing recombinant GST-CED-3 221-503 were typically assembled in a final volume of 100 µl, containing 50 µM Ac-DEVD-AFC, Ac-LEHD-AFC, Ac-IETD-AFC, or Ac-YVAD-AFC in PRB. Fluorescence was then measured in an automated fluorimeter (Spectrafluor Plus, TECAN, UK) at wavelengths of 430 nm (excitation) and 535 nm (emission).
Coupled in vitro transcription/ translation-35 Smethionine-labeled proteins were generated using the TNT kit (Promega) as described previously (Martin et al., 1996) . Typically, 25 µl reactions were assembled containing 0.5 µg of template 3 plasmid DNA and 2 µl of translation grade 35 Smethionine (1000 mCi/ ml, MP Biomedicals, UK).
Nematode cell-free reactions-Bristol N2 strain C. elegans were harvested from a 250 ml liquid culture by centrifugation at 500 g for 5 mins. Nematodes were washed twice in 50 ml of 100 mM NaCl, added to 20 ml of 60 % sucrose and centrifuged for 5 mins at 5000 g. Worms were immediately removed from the sucrose and washed in 100 mM NaCl. Following a final centrifugation at 500 g, pelleted worms were resuspended in 2 volumes of extract buffer (20 mM HEPES-KOH, pH7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 100 µM PMSF, 10 µg/ml leupeptin, 2 µg/ml aprotonin). Resuspended worms were lysed by sonication and insoluble material was pelleted for 15 mins at 15,000 g. CED-3 was added to soluble C. elegans extract at 130 nM (as determined by active site titration with z-VAD-fmk) unless otherwise indicated. Reactions were incubated for 2 h at 37 o C to facilitate CED-3-dependent proteolysis. Cell free reactions were then assessed by immunoblotting or subjected to two-dimensional electrophoresis as described. (4) 15 h at a constant 3500 V. Following isoelectric focusing, IPG strips were prepared for second dimension SDS-PAGE by a 10 min incubation in reducing buffer (2 % w/v DTT in 6 M Urea, 375 mM Tris HCl, pH 8.8, 2 % SDS, 20 % Glycerol), followed by a 10 min incubation in alkylating buffer (2.5 % w/v iodoacetimide in 6 M Urea, 375 mM Tris HCl, pH 8.8, 2 % SDS, 20 % Glycerol). Strips were then mounted on 12 % SDS-PAGE gels using 1-2 ml of easymelt agarose (Biorad, UK) and electrophoresed at 37.5 mA per gel in a Biorad Protean IIxi electrophoresis cell (Biorad, UK).
T w o -d i m e n s i o n a l e l e c t r o p h o r e s i s -
Silver Staining of two-dimensional gels-Proteins were visualized using a Mass Spectrometry-compatible silver staining protocol as previously described (14) . Silver-stained gel images were acquired using a digital camera and were visually inspected for CED-3-dependent changes in spot patterns.
In-gel protein digestion and identification by MALDI-TOF mass-spectrometry-Candidate protein spots were excised from 2-D gels, in-gel digested with trypsin, extracted, and identified by MALDI-TOF mass spectrometry (ABI Voyager DE-Pro), as previously described (14) .
Cell culture and induction of apoptosis-CEM cells were cultured in RPMI 1640/ 10 % fetal calf serum under standard conditions. Apoptosis was induced by incubation in indicated concentrations of actinomycin D, TPCK or DCI. To quantitate apoptosis, cells were stained with annexin V-FITC at 1 µg/ml and propidium iodide at 10 µg/ml in annexin V binding buffer (10 mM Hepes-NaOH, pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 ). Cell fluorescence was measured on a flow cytometer (FACSCalibur, Becton Dickinson, CA).
Immunostaining-Cells were washed with PBS containing 3 % BSA and 0.05 % NaN 3 , followed by a 15 minute incubation in the same buffer. Antibodies were added at 1:400 and incubated for 1 hour. After a further three washes, secondary antibody was added at 1:500 for 1 hour. Cells were washed another three times and fixed for 15 minutes in PBS/ 3% PFA, then prepared for flow cytometry.
Preparation of Cell Lysates-Cells were pelleted at 800 g and resuspended at 2 x 10 7 cells/ ml in SDS-PAGE loading buffer (2 % SDS, 50 mM Tris-HCI, pH 6.8, 10% glycerol, 2.5 % β-mercaptoethanol). Lysates were assessed by immunoblotting.
Preparation and activation of Jurkat cell-free extracts-Cell-free extracts were prepared from human Jurkat cells and caspases were activated by addition of cytochrome c and dATP to these extracts, as described previously (14, 15) . born in the C. elegans hermaphrodite, 131 of these die in a programmed manner (16) . Preliminary studies established that it was not possible to induce coordinate programmed cell death in worm embryos or in the somatic cells of adult worms using UV radiation, microtubule-disrupting drugs, or inhibitors of protein or RNA synthesis (RT and SJM; data not shown). The latter stimuli readily trigger apoptosis in fly and mammalian cells and their failure to do so in the worm suggests that a damage-associated programmed cell death pathway is absent in the majority of somatic cells in the nematode. Because it was not possible to obtain homogenous populations of dying cells from worm embryos or larval stages, we adopted a biochemical approach to finding CED-3 substrates. This involved generating homogenates from mixed-stage worm populations to which recombinant active CED-3 was added.
RESULTS

CED-3 displays characteristics of initiator and effector caspases-Programmed
To obtain recombinant CED-3 we generated a variety of expression constructs including; full length CED-3, a truncated CED-3 lacking the Nterminal prodomain, and constructs encoding the large and small subunits individually. However, most of these failed to produce soluble protein and several denaturation and re-folding strategies proved unsuccessful (data not shown). Recombinant active CED-3 was produced by removing the N-terminal CARD domain of the protease (aa 1-220), and replacing with glutathione S-transferase (GST; Figure 1A and B). Purified GST-CED-3 fusion protein exhibited robust proteolytic activity against several synthetic caspase substrate peptides including DEVD-AFC, IETD-AFC and LEHD-AFC ( Figure 1C ). In contrast, CED-3 did not hydrolyze YVAD-AFC, a substrate that is commonly preferred by inflammatory caspases in mammals. CED-3 exhibited a preference for DEVD-AFC, which is typical of mammalian effector caspases such as caspase-3, but was also capable of cleaving IETD-AFC and LEHD-AFC relatively efficiently ( Figure  1C ). Importantly, an N-terminally His-tagged CED-3 construct also displayed similar activity towards tetrapeptide substrates (Supplemental Figure S1 ), suggesting that addition of the Nterminal GST moiety did not significantly alter the specificity of CED-3 towards peptide substrates. Thus, CED-3 appears to be more promiscuous than the major effector caspase in mammals (caspase-3), which is consistent with the role of CED-3 as the only essential effector, as well as initiator, caspase in the worm.
We also assessed the catalytic activity of recombinant CED-3 using protein substrates that were produced by coupled in vitro transcription/translation. CED-3 has previously been reported to cleave its own precursor, consistent with its ability to autoactivate (17). Moreover, CED-3 is also reported to cleave the cell death inhibitor CED-9 in vitro (18) . Therefore, we titrated recombinant GST-CED-3 onto 35 S-labeled pro-CED-3 and 35 S-labeled CED-9 to assess the ability of CED-3 to cleave these proteins ( Figure 1D ). As Figure 1D illustrates, CED-3 cleaved its own precursor to fragments of 17 kDa and ~13 kDa consistent with separation of the large and small subunits through proteolysis at Asp374 and Asp388. However, addition of C. elegans homogenate (see below) significantly attenuated the activity of GST-CED-3 towards both 35 S-labeled substrates ( Figure 1D and Supplemental Figure S2 ).
CED-3-mediated proteolysis of pro-CED-3 and CED-9 was also largely suppressed by the poly-caspase inhibitor, z-VAD-fmk ( Figure 1E ).
CED-3-dependent proteolysis in C. elegans homogenates-To screen for CED-3 substrates within the C. elegans proteome, we generated worm homogenates as follows. Mixed-stage populations of C. elegans were grown in liquid cultures until bacteria were entirely cleared as this facilitated the elimination of contaminating E. coli from the worm digestive tracts. Worms were then washed several times in M9 buffer followed by purification over sucrose gradients. Homogenates of worm populations were generated by brief sonication and the resulting protein preparations were clarified by centrifugation at 15,000 g to eliminate unbroken worms and empty cuticles (Supplemental Figure S3) . These preparations were then incubated for 2 h at 37 o C in the presence or absence of recombinant CED-3. The concentration of CED-3 chosen was based upon preliminary titrations of recombinant CED-3 against known substrates, in the presence and absence of worm homogenates (as shown in Figure 1D ). Proteins were separated by onedimensional SDS-PAGE. As shown in Figure 2A , incubation of C. elegans homogenates with active GST-CED-3 failed to reveal any obvious alterations to the worm proteome suggesting that at Hauptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on www.jbc.org Downloaded from CED-3 is a highly specific protease that cleaves relatively few substrate proteins, at least at concentrations where this protease can process its own precursor ( Figure 1D) .
We next analysed similar CED-3-treated worm homogenates using two-dimensional (2D) SDS-PAGE and these analyses were successful in detecting ~ 40 alterations to the 2D protein spot patterns ( Figures 2B and 2C , Supplemental Figure  S4 ). Altered protein spots were then excised from the gels and proteins were identified by MALDI-TOF mass spectrometry. As illustrated in Figure  3A and Supplemental Table I , 22 proteins were identified as undergoing CED-3-dependent proteolysis under these conditions. These included proteins involved in a diverse range of cellular functions. Of note, several homologues of known human caspase substrates were identified, including the cytoskeletal proteins actin, myosin and α-tubulin (19, 20) ; a 14-3-3 protein (21); and a nucleosome assembly protein-1 homologue (22) . Additionally, several of the substrates identified, including actin, myosin, tubulin, and calreticulin have previously been implicated in apoptosisassociated events in mammalian systems (20, (23) (24) (25) .
Validation of CED-3 substrates-To confirm that the identifed proteins were bona fide CED-3 substrates rather than 2D-PAGE running artifacts, we cloned several of the genes encoding these proteins and explored whether in vitro transcribed and translated forms of these proteins were cleaved by CED-3 in vitro. As Figure 3B -D illustrates, 14-3-3 family protein 2 (FTT-2), calreticulin (CRT-1), and tubulin beta 2 (TBB-2) were cleaved by CED-3 with comparable efficiency to the known substrates pro-CED-3 and CED-9. In contrast, a panel of control worm proteins failed to undergo substantial proteolysis under the same conditions (Supplemental Figure  S5) .
Sites of CED-3-mediated cleavage in FTT-2, CRT-1 and TBB-2 were mapped by site-directed mutagenesis as shown in Figure 3B -D. In the case of FTT-2, a single CED-3 cleavage site (Asp240) appeared to be responsible for the proteolysis seen, as mutation of this site completely suppressed FTT-2 cleavage by CED-3 ( Figure 3B ). In the case of TBB-2, mutation of three potential sites individually caused changes in the pattern of substrate proteolysis (data not shown) while mutation of all three sites simultaneously resulted in only a partial reduction in substrate cleavage efficiency, suggesting that multiple CED-3 cleavage sites are present in TBB-2 ( Figure 3C) . A similar situation prevailed in the case of CRT-1, although mutation of three candidate sites in this protein did substantially attenuate proteolysis by CED-3 ( Figure 3D ). The majority of the sites found in these substrates were found to match the consensus DXXD (Table I) , which is also typical of mammalian effector caspases. In addition, where multiple cleavage sites existed within a particular substrate, sites matching the DXXD consensus were the most efficiently cleaved (data not shown).
Cleavage of human homologues-While it was not possible due to the lack of suitable antibodies to explore whether all CED-3 substrate homologues were also caspase substrates in man, we were able to confirm this in the case of FTT-2 homologues 14-3-3 β, ε and τ, TBB-2 homologue β-tubulin isoform 5, and CRT-1 homologue calreticulin. As shown in Figure 4A , three human 14-3-3 isoforms underwent caspase-mediated proteolysis in a human cell-free system based on Jurkat cell-free extracts, while a fourth isoform, 14-3-3 ζ, remained uncleaved (data not shown). Human β -tubulin and calreticulin were also confirmed to be caspase substrates in apoptotic cell extracts ( Figure 4B and C) .
Calreticulin is cleaved during apoptosis and exposed on the surface of apoptotic cells-The identification of the ER chaperone calreticulin as a caspase substrate was particularly interesting, as a recent report has shown that calreticulin is exposed on the cell surface during apoptosis (25) . Cell surface-exposed calreticulin acts as a ligand for CD91 on phagocytes, leading to engulfment of the apoptotic cell (25) . Thus, calreticulin appears to act as an inducible engulfment signal, the appearance of which on the cell surface may be controlled by caspases.
To explore this possibility, we first assessed whether cleavage of calreticulin occured in human CEM cells after exposure to a range of pro-apoptotic stimuli (actinomycin D, TPCK and DCI). Proteolysis of calreticulin was indeed observed during apoptosis, although a relatively small proportion of the total cellular protein appeared to be cleaved in comparison to substrates such as XIAP and Figure 4D ). Because the majority of calreticulin in healthy cells is contained within the ER, this protein is largely inacessible to caspases, which may explain the inefficient proteolysis seen during apoptosis. In contrast, when in vitro transcribed and translated calreticulin was added to cell-free extracts, where this protein was not protected by ER, very robust proteolysis of calreticulin was observed ( Figure 4C) .
We then explored whether surface exposure of calreticulin during apoptosis could be detected by immunostaining with an anti-calreticulin antibody, as recently reported (25) . As Figure 5A illustrates, whereas healthy CEM cells exhibited little surface immunoreactivity for calreticulin (Crt), this changed dramatically upon exposure to Act D, DCI or etoposide (VP-16), all of which promoted robust apoptosis under these conditions. Significantly, when these cells were treated with the caspase inhibitor z-VAD-fmk, surface exposure of calreticulin was profoundly inhibited ( Figure 5B ). In addition, CEM cells stably expressing the apoptosis-inhibitory protein Bcl-2 also failed to exhibit an increase in surface calreticulin upon exposure to Act D ( Figure 5C ). In contrast, surface expression of calreticulin was readily detected in wild type CEM cells under the same conditions ( Figure 5C ). Thus, caspase activity appears to be essential for the cell surface exposure of calreticulin during apoptosis.
DISCUSSION
In this study, we have identified 22 novel substrates of the C. elegans caspase CED-3. As only four CED-3 substrates have been identified to date (17,18,26) the present study represents a significant advance in our understanding of how CED-3 coordinates cell death. The substrates identified herein may be enriched in proteins that play important roles during CED-3-dependent cell death in the worm. Further analysis of the roles of these substrates may also yield novel insights into the execution phase of apoptosis in multiple organisms.
It is important to note that the approach we have used to identify CED-3 substrates has several potential drawbacks. First, due to the use of worm homogenates in our study, compartmentalization of many proteins will have been disrupted and this may render such proteins more accessible to CED-3-mediated proteolysis than in intact cells. Second, we have used recombinant GST-CED-3 at concentrations that may well be significantly higher (or lower) than in worm cells undergoing programmed cell death. Due to the lack of suitable antibodies to measure this, the concentration of CED-3 expressed in worm cells undergoing PCD remains unknown. Third, the use of 2D gels restricted us to visualizing only the most abundant proteins within the worm proteome. Thus, there is a high probability that numerous additional C. elegans proteins, of relatively low abundance, are also subjected to proteolysis by CED-3 during cell death.
These caveats beg the question of why we pursued the biochemical approach adopted in this study, as opposed to analyzing CED-3-dependent proteolysis in dying worm cells for example? The answer to this is very straightforward. Due to the very small percentages (~12%) of cells undergoing developmental PCD in the worm, coupled with the fact that such cell deaths are asynchronous, it was technically unfeasible to detect CED-3-dependent changes to the worm proteome using intact worms or embryos (data not shown). Furthermore, as noted in the Results section, numerous attempts to induce coordinate cell death in worm embryos or adults (using UV radiation, cancer chemotherapeutic drugs, protein and RNA synthesis inhibitors and heat-shock) were unsuccessful (RT and SJM, data not shown). Indeed, it is likely that the combination of these factors have contributed to the remarkable paucity of knowledge concerning the mechanism of action of CED-3 during worm PCD.
CED-3 plays a dual role in worm PCD, acting as an initiator as well as an executioner caspase in this organism. We also explored the relationship of CED-3 to human caspase-3 in terms of substrate specificity. Using fluorogenic peptide substrates, CED-3 exhibited a clear preference for DEVD-AFC, reflecting its close relationship to the human executioner caspase-3. Indeed, the closest sequence homologues of CED-3 in humans are the executioner caspases caspase-3 and caspase-7. However, CED-3 exhibited a higher degree of promiscuity in its ability to hydrolyse the substrates IETD-AFC and LEHD-AFC, reflecting its broader role in C. elegans PCD. This preference was reflected in the CED-3 cleavage sites identified in protein substrates (Table I) DXXD consensus. Amongst the other sites, the P4 aspartate was substituted for glutamic acid (2 sites), asparagine (2 sites) or valine (1 site). Where multiple sites were present, DXXD sites were the most readily cleaved (data not shown). Interestingly, the P1' site was in all but one case occupied by a small amino acid, suggesting that CED-3 cleavage site specificity may extend further than the traditional tetrapeptide motif, as suggested for several of the human caspases (27) .
During the execution phase of apoptosis, cells undergo a stereotypical set of morphological changes including detachment and rounding, membrane blebbing, fragmentation of chromatin and cellular organelles, formation of apoptotic bodies, and the exposure of "eat-me" signals for phagocytes. In keeping with this, proteins targeted by CED-3 are involved in diverse cellular functions. Notably, several are components of the cytoskeleton, and these substrates already have known roles in apoptosis-associated events. Actin and myosin are thought to provide the contractile force for cell blebbing and fragmentation (23, 24, 28) , while changes in microtubules may act to transport fragmented chromatin or phagocytic effectors into late stage blebs (29) . As removal of the C-terminus of human α-tubulin by the serine protease granzyme B results in increased rates of polymerization (20) , it may be that removal of tubulin C-termini by proteases is a common mechanism of functional disruption of microtubules during apoptosis.
Changes in apoptotic cells require energy and during early stages of apoptosis ATP-generation systems remain unperturbed. However, later stages of apoptosis are characterized by a shutdown of energy production, and cleavage of ATP synthase subunits may contribute to this. Interestingly, the vacuolar ATP synthase of which VBA-13 is a subunit has been recently implicated in generating the acidic conditions required for neurodegeneration (30) . This suggests that disabling the vacuolar ATPase may prevent dying cells from undergoing necrosis before completion of the PCD pathway. In addition, many substrates identified here are involved in cellular metabolism. This may reflect a general shutdown of energy-consuming processes in apoptotic cells. It may also help to ensure the irreversibility of the apoptotic process, as cells are unable to survive once essential processes are shut down. However, the abundance of metabolic proteins identified in this analysis is possibly due to the proteomics technology used as 2D electrophoresis reveals the most abundant proteins within the proteome, among which proteins with metabolic functions are over-represented.
Other cleavage events may function to disable cell survival pathways. 14-3-3 proteins such as FTT-2 play roles in several survival pathways, and have already been identified as substrates of human caspases (21) . Chaperone proteins may also be targeted during apoptosis to prevent futile attempts to prolong survival. Interestingly, the chaperone substrate calreticulin is required for necrosis in C. elegans (31) . Recent studies also suggests that calreticulin is exposed on the cell surface during apoptosis and acts as a signal allowing phagocyte attachment and cell engulfment (25, 32) .
Furthermore, caspasedependent exposure of calreticulin in response to certain pro-apoptotic stimuli appears to influence the immunogenicity of tumors (32) . Thus, dying cells with elevated levels of surface calreticulin provoked strong immune-mediated clearance which may be related to the efficiency of uptake of the latter cells by dentritic cells (32) . Here we have provided evidence that cleavage of calreticulin by caspases influences its surface exposure by a mechanism that remains to be defined.
Another intriguing observation was the identification of two aspartic proteases as CED-3 substrates. This raises the possibility that a protease activation cascade exists in the worm, involving aspartic as well as caspase proteases. In mammalian systems, it has frequently been suggested that proteases other than caspases may play a role in cell death. This leaves open the possibility that some of the proteins altered in our analysis may in fact be targets of these other proteases, and are therefore indirect results of CED-3 activation. Alternatively, because these aspartic proteases are related to proteases implicated in necrotic cell death in C. elegans (33) , cleavage by CED-3 might inactivate such proteases to ensure that cells undergoing PCD do not manifest necrotic changes. The observation that 4 of the 22 substrates identified here are potentially required for necrosis in C. elegans may reflect a general strategy to prevent diversion of apoptotic cells into necrosis.
While few substrates for CED-3 have previously been described, almost 400 substrates for the mammalian caspases have now been identified (34) . However, the vast majority of these substrates have been identified, at random, over a period of 10 years or so. Few systematic searches for caspase substrates, similar to the one reported here, have been conducted to date. One recent study used a non-gel chromatographicbased approach, coupled with mass spectrometry, to search for human caspase substrates in Jurkat cells undergoing apoptosis in response to CD95 receptor ligation (22) . This approach yielded 92 putative caspase substrates, some of which were validated as bona fide substrates for these proteases. The latter study adopted a novel and sensitive method for the detection of newlygenerated protein N-termini (22) . However, even with sophisticated methods such as those employed by Van Damme et al., (22) , it is clear that proteomics-based screening approaches do not completely cover the proteome, as several hundred known caspase substrates were not detected by this approach (34) . Clearly, several factors can influence the likelihood of detecting proteolysis of particular proteins, including: the source of the tissue used for the analysis (which will have an impact on the relative abundance of particular proteins), the analytical method employed (e.g. some proteins resolve very poorly on 2D gels due to size and charge issues, some peptides do not fly well in mass spectrometers), the efficiency of proteolysis of particular substrates, and other factors. Because of the above considerations, it is highly likely that many more substrates for CED-3 will be found by using complementary approaches.
In summary, this study provides the first detailed analysis of the proteins that undergo CED-3-dependent proteolysis in the nematode C. elegans and reveals that CED-3 targets a relatively restricted set of proteins to coordinate cell death, many of which are conserved caspase substrates in mammals. 221-503 were added to were 200, 130, 100, and 80 nM. Reactions were incubated for 2 hours at 37 °C followed by electrophoresis on 12 % SDS-PAGE gels.
(E) 35 S-Met-labelled CED-3 and CED-9 were incubated for 2 hours at 37 °C with 100 nM of GST-CED-3 221-503 and a range of concentrations of the caspase inhibitor z-VAD-fmk, followed by electrophoresis on 12% SDS-PAGE gels. 
Alignment of CED-3 cleavage sites
Sites of CED-3-mediated cleavage identified by site-directed mutagenesis in FTT-2, TBB-2 and CRT-1 were aligned with known CED-3 cleavage sites in CED-3 and CED-9. This alignment was used to derive a consensus sequence for CED-3-mediated protein cleavage motifs. 
